According to a new report, published by KBV research, The Global Disease Management Apps Market size is expected to reach $18.7 billion by 2029, rising at a market growth of 12.2% CAGR during the forecast period.
The Mental Health segment is showcasing a CAGR of 12.9% during (2023 - 2029). The growth of the mental health segment is attributed to growing mental health concerns, significant demand for efficient and effective mental health management systems, and beneficial characteristics of mental health applications such as tailored care plans and health data analysis. In addition, rising urbanization, a changing lifestyle, and increased demand for stress management techniques drive this market's growth.
The Smartphones segment is leading the Global Disease Management Apps Market by Device in 2022 thereby, achieving a market value of $9.2 billion by 2029. The demand for smartphones is expected to increase throughout the forecasted period due to ongoing product innovations in functions and features, growing consumer interest in fitness tracking and health monitoring, and increased demand for high-tech products. Additionally, the introduction of smartphones by manufacturers that can track certain vitals like breathing and heart rates is boosting the market's uptake.
The iOS segment has shown the growth rate of 12.6% during (2023 - 2029). The strong growth of the market is attributed to factors such as rising demand for smart medical devices with built-in health apps, rising penetration of Apple merchandise in developed and developing economies, and improved standards of privacy as well as curated content in iOS platforms. Additional factors driving the expansion of the segment forward include increased product downloads and an increase in new product launches for iOS platforms.
The North America market dominated the Global Disease Management Apps Market by Region in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $6.6 billion by 2029. The Europe market is exhibiting a CAGR of 11.8% during (2023 - 2029). Additionally, The Asia Pacific market would showcase a CAGR of 13.2% during (2023 - 2029).
Full Report: https://www.kbvresearch.com/disease-management-apps-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Fitbit, Inc. (Google LLC), Sleepcycle AB, Noom, Inc., Medisafe Project Ltd., Azumio, Inc., Healthy.io Ltd., MyFitnessPal, Inc., Curable, Inc., Bearable Ltd and Omada, Health, Inc.
By Indication
By Device
By Platform Type
By Geography
Companies Profiled
Unique Offerings 
